Agreements reached under this partnership
Business alliance- 1
Supply of REMED products in the Japanese market and exploration of business opportunities
- 2
Two-way sharing of market information and related technical guidance
- 3
Joint consideration and formulation of market entry strategies
- 4
Other matters of cooperation mutually agreed by the two companies
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The impact of this matter on our financial results will be minor, but we believe it will contribute to improved financial results and corporate value over the medium to long term.
| Item | Details |
|---|---|
| Name of alliance partner | Remed Co., Ltd.（韓：(주)리메드） |
| Alliance partner's business activities | Research, development, manufacture and sale of non-invasive electromagnetic medical devices, including transcranial magnetic stimulation devices (TMS), neuromuscular magnetic stimulation devices (NMS) and extracorporeal shock wave therapy devices (ESWT), for the fields of brain rehabilitation, chronic pain and aesthetics |
| Alliance partner's location | Yuseong-gu, Daejeon Metropolitan City, South Korea |
| Alliance partner's capital | KRW 3.06 billion (approximately ¥306 million) |
| Alliance partner's net sales | KRW 24,505 million (approximately ¥2,451 million), fiscal year ended December 2025 |
| Alliance partner's operating income | KRW 726 million (approximately ¥73 million), fiscal year ended December 2025 |
| Type of alliance | Business alliance |
| Details of the alliance | Supply of REMED products in the Japanese market and exploration of business opportunities, Two-way sharing of market information and related technical guidance, Joint consideration and formulation of market entry strategies, Other matters of cooperation mutually agreed by the two companies |
| Contract Period | 1 year from the signing date (21 April 2026), with early termination permitted by mutual agreement or written notice from either party |
| Contract Date | 21 April 2026 |
| Alliance start date | From 2026 onward (planned; start of sales and implementation support) |
| Impact on Business Performance | The impact of this matter on our financial results will be minor, but we believe it will contribute to improved financial results and corporate value over the medium to long term. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The companies determined that combining アトラグループ’s customer network with REMED’s therapeutic device technology is expected to enable them to provide new value in the fields of brain rehabilitation, chronic pain and aesthetics, expand both companies’ businesses and improve service quality for customers.